Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel biomarker has potential for predicting and treating skin cancer metastasis

2.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

3.

Atezolizumab Consolidation Impresses in High-Risk DLBCL

4.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

5.

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot